Norian currently manufactures orthobiosurgery products that are exclusively distributed by Synthes. As part of the companies’ long-term supply agreement, Kensey Nash will manufacture Norian products and Synthes will exclusively distribute them. The companies also signed a research and development agreement to create certain related future products.
Also, manufacturing of the Norian product will move from a Synthes facility in West Chester, Pa., to a Kensey Nash facility in Exton, Pa., over 18-24 months.
Read the release report on the acquisition of Synthes subsidiary.
Related Articles on Synthes:
Johnson & Johnson’s Synthes Takeover May Spur More Orthopedic Deals
Johnson & Johnson to Acquire Synthes for $21.3B
Johnson & Johnson Shareholders Uphold Use of Animals in Surgery
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
